Patent offices

Lantern Pharma Announces Filing of Seven Patent Applications Globally on Novel DNA-Damaging Agent with Anticancer Properties

Retrieved on: 
Wednesday, March 17, 2021

platform to transform oncology drug discovery and development today announced that it has filed seven patent applications globally on a novel DNA-damaging agent with anticancer properties.

Key Points: 
  • platform to transform oncology drug discovery and development today announced that it has filed seven patent applications globally on a novel DNA-damaging agent with anticancer properties.
  • Based on Lantern's previously filed PCT ("Patent Cooperation Treaty") patent application, Lantern has filed national stage patent applications to seek protection for LP-284 in major market countries throughout the world.
  • The national stage patent applications allow, if granted, for patent protection of LP-284.The filed, multi-national patent applications are directed to both the composition and manufacture of LP-284.
  • These seven patent applications are consistent with our focus on becoming a leader in the global development of precision oncology therapies," said Mr. Sharma of Lantern Pharma.

Giant Oak's GOST Search Tool Awarded U.S. Patent

Retrieved on: 
Tuesday, March 16, 2021

ARLINGTON, Va., March 16, 2021 /PRNewswire/ -- Today, Giant Oak, Inc. announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.

Key Points: 
  • ARLINGTON, Va., March 16, 2021 /PRNewswire/ -- Today, Giant Oak, Inc. announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.
  • 10,885,124 is employed primarily in Giant Oak's hosted SaaS solution, GOST (Giant Oak Search Technology).
  • 10,885,124 or about GOST (Giant Oak Search Technology), please visit giantoak.com or email [email protected] .
  • GOST is an open-source search and triage tool that builds a custom internet domain and organizes information to detect suspicious behavior.

Voleo Announces Receipt of United States Patent

Retrieved on: 
Friday, March 12, 2021

Vancouver, British Columbia--(Newsfile Corp. - March 12, 2021) - Voleo Trading Systems Inc. (TSXV: TRAD) ("Voleo") is pleased to announce the receipt of United States Patent 10,937,098 for the United States Patent and Trademark Office (USPTO) for patent claims covering certain aspects of Voleo's technology.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - March 12, 2021) - Voleo Trading Systems Inc. (TSXV: TRAD) ("Voleo") is pleased to announce the receipt of United States Patent 10,937,098 for the United States Patent and Trademark Office (USPTO) for patent claims covering certain aspects of Voleo's technology.
  • Voleo's technology platform remains operational and a complete technical analysis of Voleo's software ecosystem has been undertaken.
  • Voleo's intellectual property is secure and can be quickly deployed into a fresh, new environment.
  • Voleo also announces that it has issued a total of 1,425,000 stock options to directors, officers and consultants, with the stock options exercisable at $0.25 for a five-year period.

PyroGenesis Announces European Patent Office’s Intent to Grant Plasma Atomization (3D Printing) Patent; Increasing Productivity and Further Controlling Particle Size Distribution

Retrieved on: 
Thursday, March 11, 2021

Specifically, this patent aims at providing a simplified device geared to increasing productivity while at the same time allowing for further control over particle size distribution, thereby reducing overall costs.

Key Points: 
  • Specifically, this patent aims at providing a simplified device geared to increasing productivity while at the same time allowing for further control over particle size distribution, thereby reducing overall costs.
  • This patent has been filed for patent protection in an additional six different jurisdictions.
  • European patents provide protection not only in the 38 member states of the European Patent Organization, but also in two extension states plus four validation states.
  • This represents an area with approximately 700 million inhabitants1, said Pierre Carabin, Chief Technology Officer of PyroGenesis.

Annovis Bio Receives Japanese Patent for the Treatment of Acute Brain or Nerve Injury

Retrieved on: 
Wednesday, March 10, 2021

"This new patent further strengthens our intellectual property focused on the treatment of neurodegenerative diseases," commented Maria Maccecchini, Ph.D., CEO of Annovis.

Key Points: 
  • "This new patent further strengthens our intellectual property focused on the treatment of neurodegenerative diseases," commented Maria Maccecchini, Ph.D., CEO of Annovis.
  • "We believe there are additional opportunities to expand our patent coverage both globally and in the US.
  • The Company received its first PD patent (US 10,383,851) from the USPTO in August 2019 and its first AD patent (EP 2683242) from the European Patent Office (EPO) in March 2020.
  • The EPO approved Annovis Bio's first acute patent (EP 3334425B1) in December 2020.

Clarification of Previously Announced Press Release: SoLVBL Solutions Inc. Announces Update on the Second Provisional Patent Application

Retrieved on: 
Tuesday, March 9, 2021

Provisional Patent Application" (the "Original Press Release").

Key Points: 
  • Provisional Patent Application" (the "Original Press Release").
  • Due to recent queries regarding the Original Press Release, the following press release provides additional information and clarification on certain statements regarding filing of the Second U.S.
  • Provisional Patent Application with the United States Patent and Trademark Office (the "Second U.S.
  • In the Original Press Release, the Company set out the parameters of the Second U.S.

Point-of-Sale Integration Patent Issued to Revolution, Functionality Optimizes Restaurant Digital Order Flow

Retrieved on: 
Friday, March 5, 2021

BELLEVUE, Wash., March 5, 2021 /PRNewswire-PRWeb/ -- Restaurant Revolution Technologies (Revolution) today announced its ownership of a patent issued for streamlining order flow via point-of-sale (POS) integration and originating from its Order One platform.

Key Points: 
  • BELLEVUE, Wash., March 5, 2021 /PRNewswire-PRWeb/ -- Restaurant Revolution Technologies (Revolution) today announced its ownership of a patent issued for streamlining order flow via point-of-sale (POS) integration and originating from its Order One platform.
  • "We are grateful for the recent validation by the U.S. Patent Office in the issuance of our seventh patent.
  • Proper POS integration is vital for organizational velocity and digital transformation of our multi-unit restaurant clients."
  • Beyond the recent issued patent, Revolution's Order One platform is offered via two distinct digital ordering products: Order One Maverick and Order One Enterprise.

Croatia grants Lleida.net a patent for its method of receiving certified emails

Retrieved on: 
Tuesday, February 23, 2021

This patent, granted in Zagreb by theCroatianState Intellectual Property Office (SIPO), is valid for 20 years.

Key Points: 
  • This patent, granted in Zagreb by theCroatianState Intellectual Property Office (SIPO), is valid for 20 years.
  • The grant follows a patent granted for this method by the European Patent and Trademark Office in 2019.
  • It is also the method used by the Spanish FootballLeague for its audiovisual rights auction.
  • Lleida.net, which has more than 3,000 shareholders, is listed on BME Growth in Madrid, the OTCQX index in New York and Euronext Growth in Paris.

Croatia grants Lleida.net a patent for its method of receiving certified emails

Retrieved on: 
Tuesday, February 23, 2021

This patent, granted in Zagreb by theCroatianState Intellectual Property Office (SIPO), is valid for 20 years.

Key Points: 
  • This patent, granted in Zagreb by theCroatianState Intellectual Property Office (SIPO), is valid for 20 years.
  • The grant follows a patent granted for this method by the European Patent and Trademark Office in 2019.
  • It is also the method used by the Spanish FootballLeague for its audiovisual rights auction.
  • Lleida.net, which has more than 3,000 shareholders, is listed on BME Growth in Madrid, the OTCQX index in New York and Euronext Growth in Paris.

Hapbee Announces Filing of Provisional Patent Application for Bed-Related Form Factor

Retrieved on: 
Friday, February 19, 2021

VANCOUVER, BC, Feb. 19, 2021 /PRNewswire/ - Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) ("Hapbee"or the "Company"), a wellness technology company utilizing groundbreaking magnetic field technology in its Hapbee wearable, is pleased to announce it has filed a provisional patent application for its bed-related form factor with the United States Patent and Trademark Office ("USPTO").

Key Points: 
  • VANCOUVER, BC, Feb. 19, 2021 /PRNewswire/ - Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) ("Hapbee"or the "Company"), a wellness technology company utilizing groundbreaking magnetic field technology in its Hapbee wearable, is pleased to announce it has filed a provisional patent application for its bed-related form factor with the United States Patent and Trademark Office ("USPTO").
  • The provisional patent application covers a body support system that emits ultra-low radio frequency energy (ulRFE) expected to produce predefined sensations (e.g., calm, sleepy, relax, alert, focus).
  • Hapbee has completed the Industrial Design phase of prototype development for the aforementioned bed-related form factor and has entered the Engineering Design phase of the project.
  • Hapbee is a wearable magnetic field technology company that aims to help people choose how they feel.